OpenAI may list shares on the U.S. stock market as early as the fourth quarter of 2026, but investors can get exposure to the ...
Anteris Technologies is developing DurAVR, a differentiated biomimetic TAVR device with encouraging early clinical data in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results